Risk heterogeneity of bullous pemphigoid among dipeptidyl peptidase‐4 inhibitors: A population‐based cohort study using Japanese Latter‐Stage Elderly Healthcare Database

ABSTRACT Aims/Introduction Although the association between dipeptidyl peptidase‐4 (DPP‐4) inhibitors and bullous pemphigoid (BP) has begun to be established, some studies have suggested there are risk differences among DPP‐4 inhibitors. We conducted a population‐based cohort study to examine the ri...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Yumi Harano, Yasutaka Mitamura, Peng Jiang, Takako Fujita, Akira Babazono
Format:	Artigo
Jezik:	Inglês
Izdano:	Wiley 2023-06-01
Serija:	Journal of Diabetes Investigation
Teme:	Bullous pemphigoid DPP‐4 inhibitor Drug adverse reaction
Online dostop:	https://doi.org/10.1111/jdi.14004
Oznake:	Označite Brez oznak, prvi označite!